Drugs / COVID Rehab Formula
COVID Rehab Formula
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04924881 | Jan 2022 → Jan 2023 | COVID-19 | Chinese University of Hong Kong | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID Rehab Formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04924881 ↗ |
| Known as | COVID-19 Rehab Formula | “This double-blind, randomized, placebo controlled study aims to evaluate the efficacy and safety of the combination of the two formulae [named "COVID-19 Rehab Formula (CRF)"]...” PMID 36687403 ↗ Jan 2023 |
| Known as | CRF | “This double-blind, randomized, placebo controlled study aims to evaluate the efficacy and safety of the combination of the two formulae [named "COVID-19 Rehab Formula (CRF)"]...” PMID 36687403 ↗ Jan 2023 |